PI3K

Biotech

Sensei steps back from brink by finding Faeth merger

Only a couple of months ago, Sensei was laying off staff and mulling winding down the company.

James Waldron Feb 18, 2026 10:33am

illustration of venture capital investment funding

Incyte vets raise $102M to create better PARP, PI3K drugs

Jan 24, 2024 8:38am

IPO

Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3

Sep 29, 2023 10:00am

earnings Q1 calendar

2 more biotechs report pipeline, partnership changes

May 12, 2023 11:15am

wood tools wood working whittle

Incyte scraps six R&D programs

May 2, 2023 12:48pm

FDA stop sign

FDA feedback drives MEI, Kyowa to halt blood cancer program

Dec 6, 2022 7:18am